1-240493335-G-C
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBS2_Supporting
The NM_022469.4(GREM2):āc.141C>Gā(p.His47Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,613,942 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_022469.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GREM2 | NM_022469.4 | c.141C>G | p.His47Gln | missense_variant | 2/2 | ENST00000318160.5 | NP_071914.3 | |
GREM2 | XM_047427832.1 | c.195C>G | p.His65Gln | missense_variant | 3/3 | XP_047283788.1 | ||
GREM2 | XM_047427839.1 | c.195C>G | p.His65Gln | missense_variant | 4/4 | XP_047283795.1 | ||
GREM2 | XM_011544249.3 | c.141C>G | p.His47Gln | missense_variant | 3/3 | XP_011542551.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152124Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000640 AC: 16AN: 250182Hom.: 0 AF XY: 0.0000812 AC XY: 11AN XY: 135424
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461818Hom.: 0 Cov.: 31 AF XY: 0.0000206 AC XY: 15AN XY: 727220
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152124Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74302
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 08, 2024 | The c.141C>G (p.H47Q) alteration is located in exon 2 (coding exon 1) of the GREM2 gene. This alteration results from a C to G substitution at nucleotide position 141, causing the histidine (H) at amino acid position 47 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at